Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eton Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ETON
Nasdaq
2830
www.etonpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eton Pharmaceuticals, Inc.
Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)
- Aug 28th, 2026 12:39 pm
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
- Aug 27th, 2026 4:50 am
TGTX Stock Outperforms 95% of Stocks. Here's Why.
- Aug 24th, 2026 10:56 am
Three Biotech Stocks Stick Out With Their Stellar Charts
- Aug 21st, 2026 10:09 am
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript
- Aug 20th, 2026 5:27 pm
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance?
- Aug 14th, 2026 10:20 pm
Why Top 3% Biotech Stock, Eton, Just Catapulted To A Record High
- Aug 14th, 2026 2:10 pm
Sector Update: Healthcare Stocks Decline Late Afternoon
- Aug 14th, 2026 1:51 pm
Why Eton Pharmaceuticals Is Top of the Class Today
- Aug 14th, 2026 12:58 pm
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day
- Aug 14th, 2026 11:30 am
Eton Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
- Aug 14th, 2026 6:30 am
Eton Pharmaceuticals Inc (ETON) (Q2 2026) Earnings Call Highlights: Record Revenue and ...
- Aug 13th, 2026 11:02 pm
Eton Pharmaceuticals Q2 Earnings Call Highlights
- Aug 13th, 2026 6:03 pm
Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates
- Aug 13th, 2026 4:05 pm
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
- Aug 13th, 2026 2:05 pm
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
- Aug 5th, 2026 4:50 am
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
- Aug 3rd, 2026 4:50 am
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
- Jul 29th, 2026 4:50 am
ETON Stock Jumps 10%: Why Does This Analyst See 47% Upside To Stock?
- Jul 28th, 2026 10:46 am
Scroll